miR-9: From function to therapeutic potential in cancer

被引:35
作者
Khafaei, Mostafa [1 ]
Rezaie, Ehsan [2 ]
Mohammadi, Ali [1 ]
Gerdehsang, Payam Shahnazi [3 ]
Ghavidel, Sara [4 ]
Kadkhoda, Sepideh [5 ]
Zahra, Atieh Zorrieh [5 ]
Forouzanfar, Narjes [6 ]
Arabameri, Hossein [1 ]
Tavallaie, Mahmood [1 ]
机构
[1] Baqiyatallah Med Sci Univ, Human Genet Res Ctr, POB 19395-5487, Tehran, Iran
[2] Baqiyatallah Univ Med Sci, Mol Biol Res Ctr, Syst Biol & Poisonings Inst, POB 19395-5487, Tehran, Iran
[3] Islamic Azad Univ, Damghan Branch, Dept Biol, Damghan, Iran
[4] Islamic Azad Univ, Tonekabon Branch, Dept Cell & Mol Biol, Tehran, Iran
[5] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran
[6] Mashhad Univ Med Sci, Med Genet Res Ctr, Mashhad, Razavi Khorasan, Iran
关键词
cancer therapy; microRNA; miR-9; suppressor; tumor oncogene; MICRORNA EXPRESSION PROFILES; REGULATES E-CADHERIN; FACTOR-KAPPA-B; TUMOR-SUPPRESSOR; BLADDER-CANCER; CELL-PROLIFERATION; UVEAL MELANOMA; PROGNOSTIC VALUE; DNA METHYLATION; PROSTATE-CANCER;
D O I
10.1002/jcp.28210
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Malignant neoplasms are regarded as the main cause of death around the world; hence, many research studies were conducted to further perceive molecular mechanisms, treatment, and cancer prognosis. Cancer is known as a major factor for health-related problems in the world. The main challenges associated with these diseases are prompt diagnosis, disease remission classification and treatment status forecast. Therefore, progressing in such areas by developing new and optimized methods with the help of minimally invasive biological markers such as circular microRNAs (miRNAs) can be considered important. miRNA interactions with target genes have specified their role in development, apoptosis, differentiation, and proliferation and also, confirm direct miRNA function in cancer. Different miRNAs expression levels in various types of malignant neoplasms have been observed to be associated with prognosis of various carcinomas. miR-9 seems to implement opposite practices in different tissues or under various cancer incidences by influencing different genes. Aberrant miR-9 levels have been observed in many cancer types. Therefore, we intended to investigate the precise role of miR-9 in patients with malignant neoplasms. To this end, in this study, we attempted to examine different studies to clarify the overall role of miR-9 as a prognostic marker in several human tumors. The presented data in this study can help us to find the novel therapeutic avenues for treatment of human cancers.
引用
收藏
页码:14651 / 14665
页数:15
相关论文
共 118 条
  • [1] miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
    Adam, Liana
    Zhong, Meng
    Choi, Woonyoung
    Qi, Wei
    Nicoloso, Milena
    Arora, Ameeta
    Calin, George
    Wang, Hua
    Siefker-Radtke, Arlene
    McConkey, David
    Bar-Eli, Menashe
    Dinney, Colin
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5060 - 5072
  • [2] Camelid variable fragments of heavy chain antibodies (Nanobody): its applications in research, diagnosis and therapy
    Aghamolaei, Hossein
    Gargari, Seyed L. Mousavi
    Rasaee, Mohamad J.
    Ghanei, Mostafa
    [J]. MINERVA BIOTECNOLOGICA, 2017, 29 (02) : 89 - 100
  • [3] Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer
    Alhosin, Mahmoud
    Omran, Ziad
    Zamzami, Mazin A.
    Al-Malki, Abdulrahman L.
    Choudhry, Hani
    Mousli, Marc
    Bronner, Christian
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35 : 1 - 11
  • [4] Role of nuclear factor-κB in melanoma
    Amiri, KI
    Richmond, A
    [J]. CANCER AND METASTASIS REVIEWS, 2005, 24 (02) : 301 - 313
  • [5] CAR T-cell Therapy: A New Era in Cancer Immunotherapy
    Androulla, Miliotou N.
    Lefkothea, Papadopoulou C.
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2018, 19 (01) : 5 - 18
  • [6] [Anonymous], SEM CANC BIOL
  • [7] [Anonymous], SCI REP UK
  • [8] [Anonymous], F1000PRIME REPORTS
  • [9] [Anonymous], PHYSL PHARM REGULATI
  • [10] The prognostic value of UHRF-1 and p53 in gastric cancer
    Babacan, Nalan A.
    Egilmez, Hatice Reyhan
    Yucel, Birsen
    Parlak, Ilknur
    Seker, Mehmet Metin
    Kacan, Turgut
    Bahceci, Aykut
    Cihan, Sener
    Akinci, Bulent
    Eriten, Berna
    Kilickap, Saadettin
    [J]. SAUDI JOURNAL OF GASTROENTEROLOGY, 2016, 22 (01) : 25 - 29